![]() Biosonda Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins. | ![]() Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | ![]() Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | Caprico Biotechnologies Caprico Biotechnologies (CBI) is a biotech company focused on developing and commercializing antibody reagents for flow cytometry applications. | ![]() Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | |
Founding Date | Founding Date 1992 | Founding Date 2000 | Founding Date 1988 | Founding Date 2013 | Founding Date 1887 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Miami, US HQ Ñuñoa, CL | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Norcross, US HQ | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more |
Employees | Employees N/A | Employees 1,811 | Employees 15,1068% increase | Employees 17 | Employees 34,100 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.6 b | Valuation ($) 102.2 b | Valuation ($) N/A | Valuation ($) 97.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $548.5m (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $48.2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $324.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $13.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $224.2m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $34.3b (FY, 2025) |
Net income | Net income N/A | Net income $435.1m (FY, 2025) | Net income $4.5b (FY, 2025) | Net income N/A | Net income $7.1b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised $ 15.5m |

Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View companyCaprico Biotechnologies (CBI) is a biotech company focused on developing and commercializing antibody reagents for flow cytometry applications.
View company
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View company